Bempegaldesleukin/Nivolumab and Challenges in First-line Treatment of Metastatic Urothelial Carcinoma

被引：7
|
作者：
Miron, Benjamin [1 ]
Geynisman, Daniel M. [1 ]
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA USA
来源：
EUROPEAN UROLOGY | 2022年 / 82卷 / 04期
关键词：
CHEMOTHERAPY; CISPLATIN; MULTICENTER;
D O I：
10.1016/j.eururo.2022.05.023
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：374 / 376
页数：3
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF NIVOLUMAB plus IPILIMUMAB IN FIRST-LINE TREATMENT OF ADVANCED OR METASTATIC RENAL CELL CARCINOMA IN THE NETHERLANDS
    Klijn, S.
    Van de Wetering, G.
    Malcolm, B.
    Dale, P.
    Pompen, M.
    Stevanovic, J.
    VALUE IN HEALTH, 2018, 21 : S46 - S46
  • [32] Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs
    Shingo Maeda
    Kosei Sakai
    Kenjiro Kaji
    Aki Iio
    Maho Nakazawa
    Tomoki Motegi
    Tomohiro Yonezawa
    Yasuyuki Momoi
    Scientific Reports, 12
  • [33] Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs
    Maeda, Shingo
    Sakai, Kosei
    Kaji, Kenjiro
    Iio, Aki
    Nakazawa, Maho
    Motegi, Tomoki
    Yonezawa, Tomohiro
    Momoi, Yasuyuki
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [34] Options in metastatic urothelial cancer after first-line therapy
    Alimohamed, Nimira S.
    Sridhar, Srikala S.
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2015, 9 (03) : 255 - 260
  • [35] First-Line Therapy in locally advanced or metastatic Urothelial Cancer
    Rexer, H.
    ONKOLOGE, 2012, 18 (01): : 70 - 71
  • [36] Chemotherapy, immunotherapy, or combination first-line treatment for metastatic urothelial carcinoma of the bladder: A large real-world experience
    Ranganathan, Sanjana
    Riveros, Carlos
    Xu, Jiaqiong
    Hu, Siqi
    Geng, Michael
    Huang, Emily
    Melchiode, Zachary
    Zhang, Jun
    Efstathiou, Eleni
    Chan, Keith Syson
    Wallis, Christopher J. D.
    Sonpavde, Guru
    Satkunasivam, Raj
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (09) : 291e13 - 291e25
  • [37] ONCOLOGISTS' PREFERENCES FOR FIRST-LINE (1L) TREATMENT OF LOCALLY ADVANCED/ UNRESECTABLE OR METASTATIC UROTHELIAL CARCINOMA (AUC)
    Grivas, P.
    Phani, V
    Chiu, K.
    Pawar, V
    Chang, J.
    Bharmal, M.
    VALUE IN HEALTH, 2022, 25 (01) : S162 - S162
  • [38] First-Line Therapy in locally advanced or metastatic Urothelial Cancer
    Rexer, H.
    ONKOLOGE, 2011, 17 (07): : 638 - 639
  • [39] SURVIVAL ANALYSES AND INDIRECT TREATMENT COMPARISONS (ITCS) IN FIRST-LINE METASTATIC UROTHELIAL CARCINOMA (1L MUC)
    Jevdjevic, M.
    Nickel, K.
    Teitsson, S.
    Kurt, M.
    Broughton, E.
    Jain, R.
    Kroep, S.
    VALUE IN HEALTH, 2022, 25 (07) : S333 - S333
  • [40] Bevacizumab in combination with chemotherapy in the first-line treatment of metastatic colorectal carcinoma
    Usakova, V.
    Sevcikova, K.
    Usak, J.
    Bartosova, Z.
    Mikulova, M.
    Spanik, S.
    NEOPLASMA, 2013, 60 (01) : 83 - 91
12345